Abstract
Coccidioidomycosis, a fungal infection endemic in the southwestern United States, can cause life-threatening infections in immunosuppressed patients. We report the contrasting cases of two adolescents with lupus nephritis, treated with intravenous pulse cyclophosphamide and daily oral corticosteroids, who developed pulmonary coccidioidomycosis. One patient developed a fatal form of fulminant disseminated coccidioidomycosis, while the other patient developed a solitary pulmonary Coccidioides immitis abscess which was responsive to intravenous liposomal amphotericin and fluconazole therapy. Because serologies and initial X-ray studies can be negative, definitive diagnostic studies including bronchioaveolar lavage and needle aspiration should be performed when there is clinical suspicion of coccidioidomycosis in an immunocompromised patient. Immunosuppressed patients with coccidioidomycosis should receive early intravenous amphotericin therapy and may benefit from long-term suppressive antifungal therapy to prevent relapse.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Additional information
Received: 1 May 2000 / Revised: 18 July 2000 / Accepted: 19 July 2000
Rights and permissions
About this article
Cite this article
Yorgin, P., Rewari, M., Al-Uzri, A. et al. Coccidioidomycosis in adolescents with lupus nephritis. Pediatr Nephrol 16, 77–81 (2001). https://doi.org/10.1007/s004670000468
Issue Date:
DOI: https://doi.org/10.1007/s004670000468